Anti-Human SELP Therapeutic Antibody (Crizanlizumab)
Recombinant monoclonal antibody to SELP. Crizanlizumab is a human monoclonal antibody that can be potentially used in the treatment of Sickle Cell Disease (SCD).
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-015ML |
| Pricing | Inquiry |
| Host | Human |
| Target | SELP |
| Species Reactivity | Human |
| Type | IgG2, κ |
| Applications | Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies |
| Storage | Store at -20°C for long-term storage. Avoid freeze/thaw cycles. |